The Federal Act of 12 April 2010 N 61-FZ "On the inversion of drugs" shall come into force on September 1, 2010. According to article 46 of which the primary and secondary packaging should be indicated  the form of medicines in Russian. Media raised the issue of shortage of drugs, which may arise due to the problem repackaging drugs. Member companies of the Association of Russian Pharmaceutical Manufacturers  are in the process of making changes in the regulatory documentation, so that by the deadline of medical supplies would be available for patients.

 As a result of a productive interaction Roszdravnadzor and ARPH was prepared letter dated 11 December 2009 № 01I-857/09 according the possible sale of the goods in the old packaging, within six months. This measure allowed continuously deliver drugs to the market. There was no longer need from manufacturers to receive one-time permit the sale of goods and destroy tons of packaging. ARPH is in close liaison with Government and favored the extension of this document.

«The Law was adopted and it must perform, we should not think about its quality. It was sufficient time to make changes in the regulatory documentation. Roszdravnadzor order was signed July 23, 2010 № 7090-Pr/10 "On the organization of work in connection with the entry into force 1 September 2010 the Federal Law of 12 April 2010 N 61-FZ" On circulation of drugs" that shows concern departments evolving situation. I think that in a constructive dialogue between business and government, working on the scheme proposed in the December letter of Roszdravnadzor, no shortage of medicines will be»-the General Director Victor Dmitriev stated.

Changes in the regulatory documentation is not a problem for Russian pharmaceutical producers. The only difficulties arise connected with the destruction of packaging with the old label, which does not affect the quality and effectiveness of drugs. Increasing spending may affect the cost of drugs.